Mitomycin C induces pulmonary vascular endothelial‐to‐mesenchymal transition and pulmonary veno‐occlusive disease via Smad3‐dependent pathway in rats
British Journal of Pharmacology2020Vol. 178(1), pp. 217–235
Citations Over TimeTop 18% of 2020 papers
Chenting Zhang, Wenju Lu, Xiaoyun Luo, Shiyun Liu, Yi Li, Qiuyu Zheng, Wenyan Liu, Xuefen Wu, Yuqin Chen, Jiang Qian, Zizhou Zhang, Guoping Gu, Jiyuan Chen, Hạixia Chen, Jing Liao, C. Liu, Cheng Hong, Haiyang Tang, Dejun Sun, Kai Yang, Jian Wang
Abstract
Our data indicated that targeted inhibition of Smad3 leads to a potential, novel strategy for PVOD therapy, likely by inhibiting the EndoMT in pulmonary microvasculature.
Related Papers
- → High Expression of Vimentin is Associated With Progression and a Poor Outcome in Glioblastoma(2016)75 cited
- → Research Progress on the Role of Intermediate Filament Vimentin in Atherosclerosis(2021)3 cited
- Correlation of nuclear transcription factor κB with vimentin expression in autoimmune thyroiditis(2007)
- [Immunofluorescence study of intermediate filament protein vimentin of CP-activated macrophages].(1990)
- Dexamethasone impact on vimentin in human lens epithelial cells(2016)